Industry and US administration leaders lay out their plans to navigate a globally competitive pharma landscape with China’s growing dominance.
The UK was the highest ranked country for those offshoring pharma R&D, raising questions about its pharma industry’s attractiveness.
Respondents from a GlobalData survey have identified pricing and reimbursement hurdles as one of the top three challenges facing the pharma sector over the next year.
The therapy dosing provides clinical outcomes consistent with those of the earlier approved bi-weekly subcutaneous regimen.
The anticipated growth is mainly driven by ten new pipeline drugs expected to be introduced to the market by 2034.
The partnership will combine Evogene’s computational chemistry capabilities with the expertise of a team at QUT.
